CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE

Generic: CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE

Solco Healthcare LLCManufacturer
ORALRoute
CANDESARTAN CILEXETILActive Substance
2018-04-11Original Approval

CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE is FDA application ANDA207455, sponsored by PRINSTON. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Top Reported Reactions

1
DYSPNOEA
74 reports
2
DIZZINESS
67 reports
3
GENERAL PHYSICAL HEALTH DETERIORATION
61 reports
4
HYPONATRAEMIA
58 reports
5
CONDITION AGGRAVATED
55 reports
6
ABDOMINAL PAIN
45 reports
7
NAUSEA
43 reports
8
ASTHMA
42 reports
9
FATIGUE
41 reports
10
FALL
39 reports